Insights

The New Jersey Legislature is considering two bills, that if enacted, would prohibit business entities from using either consumers' personal data or “personalized algorithmic pricing” to set prices for merchandise or services, including groceries. If enacted, the new laws would have broad implications for companies across industries that rely on algorithmic or data-informed pricing strategies. In her recent State Budget Address, New Jersey Governor Mikie Sherrill pledged to sign the proposals into law if they reach her desk.

On March 11, 2026, U.S. Patent and Trademark Office (USPTO) Director Squires issued a memorandum (2026 memo) to all Patent Trial and Appeal Board (PTAB) users titled “Additional Discretionary Institution Considerations — U.S. Manufacturing and Small Business Use of AIA Proceedings.”[1] In the 2026 memo, the director adds three new factors in determining whether to institute inter partes review (IPR) and post-grant review (PGR) proceedings.[2] The factors focus on domestic manufacturing and the use of these proceedings by small businesses.[3] The memo applies immediately to all pending IPR and PGR proceedings in which the due date for the patent owner’s discretionary brief has not yet elapsed.[4] Patent owners, petitioners with domestic manufacturing ties, and small business petitioners should take note.

In Wake Chapel Church, Inc. v. Church Mutual Insurance Company, the Fourth Circuit affirmed a $1.1 million jury verdict in favor of a policyholder, reaffirming that under North Carolina law insurers cannot defeat all-risk coverage by pointing to a postulated inherent defect or other excluded cause if a covered peril also contributed to the loss.

On 4 March 2026, Qatar’s Ministry of Commerce and Industry (MoCI) issued Ministerial Decision No. (25) of 2026 (Decision), establishing a regulatory framework (Framework) for conducting commercial activities through electronic platforms that do not require a physical premises in Qatar. The Decision was published in the Official Gazette on 15 March 2026 and entered into force on 16 March 2026.

The U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) issued six new general licenses, and updated a seventh that allow for many activities related to: the export of Venezuelan oil and petrochemical products from Venezuela; the exploration, development, and production of oil, gas, and petrochemical products in Venezuela; the generation, transmission, storage, or distribution of electricity in Venezuela; the export to Venezuela of U.S.-origin diluents; negotiating for investment in the oil, gas, petrochemical, and electricity sectors in Venezuela; and the export of Venezuelan gold.

On March 4, 2026, the European Commission proposed the Industrial Accelerator Act (IAA), a draft regulation that aims to reverse the decline of the EU’s manufacturing sector while supporting the adoption of cleaner technologies. The proposal introduces “Made in EU” and low-carbon requirements in public procurement and public support schemes, to create lead markets for European industrial products. The proposal also seeks to increase value creation in the EU and bolster the EU’s economic security by setting conditions for major foreign direct investments (FDI) in strategic sectors.

On March 6, 2026, the General Services Administration (GSA) issued a significant proposed contract clause, GSAR 552.239-7001, Basic Safeguarding of Artificial Intelligence Systems (“Clause”), for inclusion in GSA Schedule solicitations and contracts for AI capabilities.  The proposed clause would impose substantial new requirements related to AI sources, intellectual property rights, data use, change management, and performance standards.  The Clause would also take precedence over any other contract terms (including commercial licensing terms) related to AI, including a Seller’s terms of sale and service to which the Government had previously agreed.  GSA requests comments by March 20, 2026.

On March 10, 2026, the Department of Justice released the first-ever Department-wide Corporate Enforcement and Voluntary Self-Disclosure Policy (the “Department-wide CEP” or “Policy”), which applies to all non-antitrust corporate criminal cases across the Department. The new policy has been anticipated since December 2025, when Deputy Attorney General Todd Blanche announced the Department’s plans to release a new, single corporate enforcement policy for all criminal matters. According to the Department, the new policy is designed to “help ensure consistency across the Department” and “transparently describe the Department’s policies and decisionmaking.”

The EU Pharma Package represents the most significant reform of EU pharmaceutical legislation in over two decades, setting the stage for a new era in medicine regulation. Introduced by the European Commission back in April 2023, the proposals are designed to promote innovation, strengthen medicine availability and affordability, reduce regulatory burdens, ensure a fair and competitive European pharmaceutical market, and modernize the EU's pharmaceutical framework. The EU Pharma Package will replace the more than twenty-year-old Directive 2001/83/EC and Regulation 726/2004, and incorporates the separate regulations on orphan and pediatric medicines, thereby bringing the entire regulatory framework up to date.

On March 3, 2026, a bipartisan coalition of state attorneys general and state charity regulators (the “States”) sent a letter[1]to GoFundMe expressing their concerns about GoFundMe's creation of donation web pages for more than 1.4 million charities without their prior knowledge or consent.

In March 2026, the UK Government published its Fraud Strategy 2026–2029, part of a broader economic-crime policy package building on the Economic Crime Plan 2 (March 2023) and the Anti-Corruption Strategy, published in December 2025. The strategy's headline message for fraud victims is striking: do not wait for the state to act, but rather, seek redress from the court yourself.

The Court of Justice of the European Union (CJEU) has delivered a significant ruling that clarifies the rules governing evidence disclosure in competition damages litigation. The judgment addresses three critical questions: (1) whether pre-action disclosure falls within the scope of the EU Damages Directive, (2) what evidence is needed to establish that there is a plausible damages claim, and that therefore a disclosure request should be granted, and (3) how the plausibility threshold should be assessed.

On February 26, 2026, the Senate Health, Education, Labor, and Pensions (HELP) Committee voted 22-1 to advance the Health Care Cybersecurity and Resiliency Act of 2026. Sponsored by a bipartisan group — led by HELP Committee Chair Senator Bill Cassidy (R-LA); and Senators Mark Warner (D-VA), Maggie Hassan (D-NH), and John Cornyn (R-TX) — the bill represents perhaps the most significant federal legislative effort to overhaul health care cybersecurity since the passage of the Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009, and would compel health care companies to make major investments in cybersecurity.

On March 6, 2026, the White House released its National Cyber Strategy (Strategy) and issued an accompanying Executive Order, “Combating Cybercrime, Fraud, and Predatory Schemes Against American Citizens” (EO). These documents outline the administration’s priorities for combating cybercrime and call for coordination across the federal government and the private sector to invest in new technologies, continue innovation, and prioritize the United States’ cyber capabilities. Key sectors of concern include energy, financial services, telecommunications, data centers, water, and health care. The Strategy and EO encourage increased public-private coordination, signal greater latitude for private sector offensive cyber operations, prioritize securing critical infrastructure, elevate cybercrime as a national security priority, outline a path for victim compensation, and promote streamlining cyber regulations.

On 26 February 2026, the EU published Directive (EU) 2026/470 (the Omnibus I Directive). Adopted as part of the European Commission's (Commission) simplification agenda and after a year of debates and negotiations between the Commission, the Council, and the European Parliament, this text effectuates far-reaching changes to both the Corporate Sustainability Reporting Directive (CSRD) and the Corporate Sustainability Due Diligence Directive (CS3D).

On February 12, 2026, a bipartisan group of legislators in Maryland proposed the Maryland Artificial Intelligence Toy Safety Act. This proposed legislation would amend the Maryland Consumer Protection Act to establish a sweeping regulatory framework for AI-enabled toys sold in the state, covering any device that uses machine learning, conversational AI, behavioral modeling, or similar computational processes and is marketed to or primarily used by children. This proposed legislation adds to a growing trend of increasing efforts, at both the federal and state levels, to regulate the use of AI in products and services used by children.  

Chambers Ranks Crowell & Moring International Trade Practice and Lawyers in 2026 Global Guide

On March 3, 2026, the Department of Labor (DOL), Department of Health and Human Services (HHS), and Department of the Treasury (TREAS) — collectively, the “Tri-Agencies” — published their fourth annual report to Congress on enforcement of the Mental Health Parity and Addiction Equity Act (MHPAEA). The 2025 Report demonstrates a shift in approach by the Tri-Agencies in its tone and content and suggests that federal regulators, and the DOL in particular, are not as active as they previously were in MHPAEA enforcement. However, federal enforcement remains ongoing, and state enforcement of mental health parity laws continues to grow. Plans and issuers must continue to maintain comprehensive compliance processes and documentation for MHPAEA compliance.

The U.S. Department of Labor (DOL) has proposed another revision to independent contractor regulations, one that would provide for more leeway in classifying workers as contractors. DOL’s proposed rule, published on February 26, 2026, would rescind the Biden DOL’s March 2024 independent contractor regulation and reinstate a framework substantially tracking the prior Trump rule of January 2021. The proposed rule would also apply the narrower analysis to worker classifications under the Family and Medical Leave Act (FMLA) and the Migrant and Seasonal Agricultural Worker Protection Act (MSPA). The comment period closes in late April 2026; until then, the 2024 rule remains in effect for purposes of private litigation.